Related references
Note: Only part of the references are listed.Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects
Roman Huber et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points
Takeshi Sano et al.
GASTRIC CANCER (2011)
Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract
J. Eisenbraun et al.
PHYTOMEDICINE (2011)
Pharmacokinetics of natural mistletoe lectins after subcutaneous injection
Roman Huber et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies
Gunver S. Kienle et al.
INTEGRATIVE CANCER THERAPIES (2010)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
I'm so tired: biological and genetic mechanisms of cancer-related fatigue
Andrea Barsevick et al.
QUALITY OF LIFE RESEARCH (2010)
The Immune System and Cancer
David Loose et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Mucosal injury from targeted anti-cancer therapy
Dorothy M. K. Keefe et al.
SUPPORTIVE CARE IN CANCER (2007)
Correlation of NK cell activity against autologous tumour cells and K562 cells with the clinical outcome during therapy with mistletoe extracts
Michael Schink et al.
FORSCHENDE KOMPLEMENTARMEDIZIN UND KLASSISCHE NATURHEILKUNDE (2006)
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer
I Chau et al.
EUROPEAN JOURNAL OF CANCER (2005)
Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients
F Romano et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Randomized and double-blind studies - Demands and reality as demonstrated by two examples of mistletoe research
M Rostock et al.
FORSCHENDE KOMPLEMENTARMEDIZIN UND KLASSISCHE NATURHEILKUNDE (2004)
Adenocarcinoma of the stomach: Univariate and multivariate analysis of factors associated with survival
D Green et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
The difference in gastric cancer between Japan, USA and Europe: What are the facts? What are the suggestions?
PA Davis et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Share Paper
